Orchestra Bio news
The latest Orchestra Bio news, : OpenAI acquires Orchestra Bio to boost AI agents for drug development.
1 story mentioning Orchestra Bio, newest first, each with its sources and discussion. Follow to see new ones on your front page.
Funding and deals undisclosed reported
- undisclosedacquisitionOct 2026 · OpenAI
-
OpenAI acquires Orchestra Bio to boost AI agents for drug development
OpenAI announced it has acquired Orchestra Bio, a startup that builds AI agents to help pharmaceutical companies manage drug‑development tasks. The company said the acquisition will bring Orchestra’s platform—used for…
4 sourcesTechCrunch AIaxios.comcryptobriefing.comfinance.yahoo.com
Questions about Orchestra Bio
What is the latest Orchestra Bio news?
As of 20 October 2026: OpenAI acquires Orchestra Bio to boost AI agents for drug development. OpenAI announced it has acquired Orchestra Bio, a startup that builds AI agents to help pharmaceutical companies manage drug‑development tasks.
How much funding has Orchestra Bio raised?
Orchestra Bio has undisclosed in reported deals covered by Digest AI: undisclosed acquisition in October 2026.